Monday, August 31, 2020

Erasca Bumps Series B To $236M

San Diego-based cancer treatment developer Erasca announced Monday that it has completed a $36M extension to its Series B funding round, bringing that funding to $236M in total. The new funding came from such investors as Partner Fund Management and Orbimed, and brings the company's total raised to $300M. Erasca said the funds will go to finance the clini

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.